These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31584324)

  • 1. Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma.
    Jessup JM; Kabbout M; Korokhov N; Joun A; Tollefson AE; Wold WSM; Mattoo AR
    Hum Vaccin Immunother; 2020 Mar; 16(3):636-644. PubMed ID: 31584324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
    Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
    Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nanoparticles induce a non-immunogenic tumor cell death.
    Garcia Garcia MR; Casares N; Martinez Perez LA; Juarez Curiel E; de Jesus Hernandez AA; Bogdanchikova N; Garibo D; Rodriguez-Hernandez AG; Pestryakov A; Castro Gamboa S; Arias Ruiz LF; Torres Bugarin O; Berraondo P
    J Immunotoxicol; 2023 Dec; 20(1):2175078. PubMed ID: 36773297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic death of colon cancer cells treated with oxaliplatin.
    Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
    Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
    Wang D; Jiang W; Zhu F; Mao X; Agrawal S
    Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH
    Hashemzadeh A; Amerizadeh F; Asgharzadeh F; Darroudi M; Avan A; Hassanian SM; Landarani M; Khazaei M
    Toxicol Appl Pharmacol; 2021 Jul; 423():115573. PubMed ID: 33991535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
    Kanaya N; Kuroda S; Kakiuchi Y; Kumon K; Tsumura T; Hashimoto M; Morihiro T; Kubota T; Aoyama K; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Mizuguchi H; Urata Y; Fujiwara T
    Mol Ther; 2020 Mar; 28(3):794-804. PubMed ID: 31991110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice.
    Wright P; Braun R; Babiuk L; Littel-van den Hurk SD; Moyana T; Zheng C; Chen Y; Xiang J
    Cancer Biother Radiopharm; 1999 Feb; 14(1):49-57. PubMed ID: 10850287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model.
    Golchin S; Alimohammadi R; Rostami Nejad M; Jalali SA
    J Cell Physiol; 2019 Nov; 234(11):19866-19874. PubMed ID: 30941773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenoviral vector expressing an antiangiogenic fragment of thrombospondin 1 inhibits the growth of K562 cell xenografts].
    Liu P; Wang Y; Yang RC; Cai YL; Han ZC
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):485-8. PubMed ID: 12887763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
    Sarkar A; Novohradsky V; Maji M; Babu T; Markova L; Kostrhunova H; Kasparkova J; Gandin V; Brabec V; Gibson D
    Angew Chem Int Ed Engl; 2023 Oct; 62(42):e202310774. PubMed ID: 37646232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
    Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
    Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy.
    Zhang M; Berndt BE; Chen JJ; Kao JY
    J Immunol; 2008 Sep; 181(5):3690-7. PubMed ID: 18714045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma.
    Sun F; Cui L; Li T; Chen S; Song J; Li D
    J Recept Signal Transduct Res; 2019 Jun; 39(3):208-214. PubMed ID: 31441696
    [No Abstract]   [Full Text] [Related]  

  • 18. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
    You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
    Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model.
    Wang W; Wu L; Zhang J; Wu H; Han E; Guo Q
    Biochem Biophys Res Commun; 2017 May; 487(1):1-7. PubMed ID: 28042031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
    Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.